Patients can be quickly tested at the clinic and receive results within 5 minutes. This tool promises to help stem the worldwide momentum of Covid-19.
According to The Verge, the US Food and Drug Administration (FDA) has urgently approved the Covid-19 test kit developed by the medical device company Abbott, giving great hope in the fight against transmission. spread of SARS-CoV-2 virus.
With its small size, the device called ID NOW does not need to be supported by a large lab or other devices. Instead, it can be done directly in the emergency room or urgent care clinic, reducing the waiting time for test results.
Doctors can apply swabs in the nose or throat of the patient, then put them directly into the machine and receive the results within 5 minutes (takes 13 minutes if the sample is negative for the virus).
Robert B. Ford, President and CEO of Abbott, said that with ID NOW, health care providers can perform tests outside the hospital, which will quickly overload if an outbreak occurs. .
This is the second FDA-approved Covid-19 rapid test kit. Cephid, the first biotechnology product, took 45 minutes to produce results. However, it is mainly for emergency rooms and hospitals, not suitable for private clinics or urgent care centers.
The Abbott test kit has a different operating mechanism from the standard types used in the US. Typically, specimens are sent to a laboratory for PCR processing, searching for samples of the genetic material of SARS-CoV-2. This process is time-consuming, requires machine support and changes in temperature several times.
Abbott’s ID NOW also looks for viral genetic material but operates at a single temperature. That’s why it’s small in size and doesn’t need much power.
The company is planning to launch 50,000 test kits a day, starting next week.
The United States has become the country with the highest number of Covid-19 infections in the world. State and commercial laboratories run more than 100,000 tests a day, but this is still less than many other countries per capita.